1. Home
  2. CALY vs TLX Comparison

CALY vs TLX Comparison

Compare CALY & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CALY

Callaway Golf Company

N/A

Current Price

$13.98

Market Cap

2.6B

Sector

N/A

ML Signal

N/A

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$11.25

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALY
TLX
Founded
1982
2015
Country
United States
Australia
Employees
28000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CALY
TLX
Price
$13.98
$11.25
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$16.50
$21.13
AVG Volume (30 Days)
2.0M
208.0K
Earning Date
05-07-2026
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.23
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$64.24
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$12.26
$6.28
52 Week High
$16.65
$19.93

Technical Indicators

Market Signals
Indicator
CALY
TLX
Relative Strength Index (RSI) 50.44 78.64
Support Level $13.18 $10.60
Resistance Level $13.96 $12.60
Average True Range (ATR) 0.48 0.31
MACD 0.08 0.15
Stochastic Oscillator 44.83 90.71

Price Performance

Historical Comparison
CALY
TLX

About CALY Callaway Golf Company

Callaway Golf Co is a golf equipment, gear and apparel company with a portfolio of world-wide brands, including Callaway Golf, Odyssey, TravisMathew, and OGIO. Callaway designs, manufactures, and sells high-performance golf clubs, golf balls, apparel, bags, and other accessories-setting the standard for performance in the game of golf. The company has two operating and reportable business segments: Golf Equipment and Apparel, Gear and Other. Geographically, the company operates in United States, Europe, Asia, and Rest of World, of which it derives maximum revenue from United States.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: